Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

FDMT 4D Molecular Therapeutics Inc

23,97

-0,67 (-2,72%)

01 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

null

4D Molecular Therapeutics (NASDAQ:FDMT)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more 4D Molecular Therapeutics Charts.

4D Molecular Therapeutics (NASDAQ:FDMT)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more 4D Molecular Therapeutics Charts.

News 4D Molecular Therapeutics Inc

4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibrosis at 47ᵗʰ European Cystic Fibrosis Conference
Donnerstag 30 Mai 2024 (3 Tage vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 24 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 24 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 24 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 21 Mai 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 9 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

4DMT Reports First Quarter 2024 Financial Results and Operational Highlights
Donnerstag 9 Mai 2024 (3 Wochen vor) • GlobeNewswire Inc.

4DMT to Participate in Upcoming Investor Conference
Dienstag 7 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

4DMT Announces Presentations at ARVO 2024 Annual Meeting
Mittwoch 1 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

4DMT Announces Update on Regulatory Interactions and Development Path for 4D-710 for Treatment of Cystic Fibrosis
Donnerstag 28 März 2024 (2 Monate vor) • GlobeNewswire Inc.

4DMT to Participate in Upcoming Investor Conferences
Montag 4 März 2024 (3 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 1 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere 4D Molecular Therapeutics Inc News-Artikel

Deutsche Lufthansa

Health Care Select Sector

Euro vs Sterling

Financial Select Sector

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen